Voyager Therapeutics Said Co And CFO Peter P. Pfreundschuh Entered Into A Transition, Separation And Release Of Claims Agreement; Pfreundschuh Resigned From His Position AsCFO Effective On April 12, 2024
Portfolio Pulse from Charles Gross
Voyager Therapeutics announced that the company and CFO Peter P. Pfreundschuh have entered into a transition, separation, and release of claims agreement. Pfreundschuh resigned from his position as CFO effective April 12, 2024.
April 02, 2024 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics' CFO Peter P. Pfreundschuh has resigned, effective April 12, 2024, after entering a transition and separation agreement with the company.
CFO resignations can lead to short-term negative sentiment among investors due to potential uncertainties about financial leadership and strategic direction. However, since the transition is planned, the impact might be somewhat mitigated.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100